Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Shares, par value (euro)0.12 per share
-
Shares outstanding
-
22.4M
-
Number of holders
-
104
-
Total 13F shares, excl. options
-
13.7M
-
Shares change
-
-149K
-
Total reported value, excl. options
-
$750M
-
Value change
-
-$11.7M
-
Put/Call ratio
-
2.05
-
Number of buys
-
63
-
Number of sells
-
-57
-
Price
-
$54.62
Significant Holders of CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) as of Q3 2021
173 filings reported holding CVAC - CureVac N.V. - Common Shares, par value (euro)0.12 per share as of Q3 2021.
CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) has 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.7M shares
of 22.4M outstanding shares and own 61.23% of the company stock.
Largest 10 shareholders include BAILLIE GIFFORD & CO (3.94M shares), Bill & Melinda Gates Foundation (3.13M shares), BlackRock Inc. (1.11M shares), STATE STREET CORP (531K shares), PRICE T ROWE ASSOCIATES INC /MD/ (483K shares), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main (411K shares), NORGES BANK (368K shares), GEODE CAPITAL MANAGEMENT, LLC (292K shares), MILLENNIUM MANAGEMENT LLC (265K shares), and VOLORIDGE INVESTMENT MANAGEMENT, LLC (244K shares).
This table shows the top 104 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.